http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113133995-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-701 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
| filingDate | 2021-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113133995-B |
| titleOfInvention | Application of Inhibitor CNI-1493 in Porcine Reproductive and Respiratory Syndrome |
| abstract | The application belongs to the technical field of animal disease pre-control, and specifically relates to the application of the inhibitor CNI‑1493 in porcine reproductive and respiratory syndrome. As a specific inhibitor of eIF5A hydroxyproline modification, CNI-1493 is used to inhibit the proliferation of PRRSV in cells after it is treated in cells; the cells are eukaryotic cells. In this application, the invention takes MARC-145 cells as an example, and inoculates PRRSV after treating the cells with the eIF5A hydroxyproline modification specific inhibitor CNI-1493. It is preliminarily identified that the inhibitor CNI‑1493 has a certain inhibitory effect on PRRSV. Based on this result, it can lay a certain technical foundation for the prevention and control of PRRS, and also provide new ideas and references for the screening of other anti-PRRSV drugs. |
| priorityDate | 2021-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 190.